Study examines relationship between disease-modifying antirheumatic drugs and the development of diabetes among patients with rheumatoid arthritis or psoriasis.
Post-myocardial infarction patients who receive antiplatelet therapy and a selective serotonin reuptake inhibitor for coexisting depression are at increased risk of bleeding, study finds.